Oxion Biologics AB
Revolutionizing treatment for immune-mediated diseases with novel therapy.
Oversigt
- 3
- Medarbejdere
- 2.9mio SEK
- Omsætning
- 2021
- Grundlagt
Nøglebeslutningstagere
Cheng Xu
Chief Operations Officer
Felix Sellberg
Chief Scientific Officer
Peter Frank
Chief Development Officer
Robin Fröbom
Chief Executive Officer
Beskrivelse
Oxion Biologics is a clinical-stage biotechnology company based in Stockholm, Sweden, dedicated to revolutionizing the treatment landscape for immune-mediated diseases. Founded in 2021 by a specialized team possessing over 70 years of combined experience, the organization focuses intensely on scient...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559310092701
Beslutningstagere
4 kontakter i FunnelfeedrCheng Xu
Chief Operations Officer
Felix Sellberg
Chief Scientific Officer
Peter Frank
Chief Development Officer
Robin Fröbom
Chief Executive Officer
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
AQILION AB
5–9 medarbejdereDeveloping innovative treatments for chronic inflammatory diseases via early-stage partnering.
OxThera Intellectual Property AB
0 medarbejdereDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
AAX Biotech AB
5–9 medarbejdereResearch-driven biotech advancing antibody therapies via proprietary technology.
OxThera AB
0 medarbejdereDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
ARGENX BV
1–4 medarbejdereEngineering life-changing immunology solutions for severe autoimmune diseases.
Udforsk mere
Spørgsmål om Oxion Biologics AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo